Content about Microbiology

April 25, 2011

SUPPLIER NEWS — Hi-Tech Pharmacal announced the tentative approval by the Food and Drug Administration of levofloxacin oral solution in the 25-mg/mL strength, a generic antibiotic. Levofloxacin oral solution is a generic version of Johnson & Johnson’s Levaquin, which had sales of $6 million in 2010, according to IMS Health. Hi-Tech expected to receive final approval in June, when Johnson & Johnson’s patent expires.


April 25, 2011

The pharmacist isn’t just someone in a white coat who hands out bottles of pills anymore. The role of pharmacists has been changing and expanding dramatically over the last several years.

Now, pharmacists in all 50 states can offer a service previously reserved for doctors and nurses: 
administering vaccinations. Retail pharmacies across the country are racing to join the immunization trend, with Weis Markets recently announcing that it would spend the year making sure all its pharmacists were trained to give vaccinations. 


April 25, 2011

Wegmans hosts a bevy of natural solutions (e.g., gluten-free foods, supplements and homeopathic solutions) just outside its produce department, including this refrigerated unit replete with probiotics and flax-seed oil supplements. That places the mass-oriented grocer more in line with the kind of natural wellness position you would expect to find at a Whole Foods or other natural grocer. 


April 22, 2011

In response to a Food and Drug Administration warning letter, Tec Labs announced on Thursday that the company plans to work with the agency regarding its StaphAseptic first-aid antiseptic and pain-relieving gel.

ALBANY, Ore. — In response to a Food and Drug Administration warning letter, Tec Labs announced on Thursday that the company plans to work with the agency regarding its StaphAseptic first-aid antiseptic and pain-relieving gel.

The FDA on Wednesday issued a total of four warning letters, including the one to Tec Labs, to companies that manufacture and market products claiming to prevent infection from methicillin-resistant Staphylococcus aureus bacteria, or MRSA.

April 21, 2011

Rite Aid is selling whooping cough vaccines to parents in California at a reduced price, the retailer said Thursday.

CAMP HILL, Pa. — Rite Aid is selling whooping cough vaccines to parents in California at a reduced price, the retailer said Thursday.

As of July 1, a new state law will require proof of vaccination for all students entering grades 7 through 12, and nearly all of the retail pharmacy chain’s 600 stores in California will be able to vaccinate walk-in patients or by appointment. The reduced-price vaccine will sell for $57.99.

April 21, 2011

The Food and Drug Administration on Wednesday issued four warning letters to companies that manufacture and market over-the-counter drug products, including hand sanitizers, that claim to prevent infection from methicillin-resistant Staphylococcus aureus bacteria, or MRSA.

SILVER SPRING, Md. — The Food and Drug Administration on Wednesday issued four warning letters to companies that manufacture and market over-the-counter drug products, including hand sanitizers, that claim to prevent infection from methicillin-resistant Staphylococcus aureus bacteria, or MRSA.

April 21, 2011

Companies that make vaccines, drugs and diagnostic tests for influenza will become key stakeholders in the World Health Organization’s Global Influenza Surveillance Network under an agreement reached at the Open Ended Working Group that WHO coordinated to support global preparedness for a future influenza pandemic.

LONDON — Companies that make vaccines, drugs and diagnostic tests for influenza will become key stakeholders in the World Health Organization’s Global Influenza Surveillance Network under an agreement reached at the Open Ended Working Group that WHO coordinated to support global preparedness for a future influenza pandemic.

April 21, 2011

Merck and Sanofi Pasteur have started a late-stage clinical trial of a combination vaccine for six childhood diseases, the companies said Thursday.

WHITEHOUSE STATION, N.J. — Merck and Sanofi Pasteur have started a late-stage clinical trial of a combination vaccine for six childhood diseases, the companies said Thursday.

April 20, 2011

Bainbridge & Knight announced the expansion of its Lichi Super Fruit Diet brand with a probiotic product.

NEW YORK — Bainbridge & Knight announced the expansion of its Lichi Super Fruit Diet brand with a probiotic product.

New Lichi LactoSpore is a gluten- and dairy-free probiotic designed to aid in healthy digestion without uncomfortable bloating. It also helps the immune system fight off infections, the company said, and provides Bacillus coagulans, necessary bacteria.

Lichi LactoSpore probiotic will be available at leading drug stores and supermarkets nationwide.

April 20, 2011

Mylan has launched a generic drug for treating herpes, the company said Wednesday.

PITTSBURGH — Mylan has launched a generic drug for treating herpes, the company said Wednesday.

Mylan announced the launch of famciclovir tablets in the 125-mg, 250-mg and 500-mg strengths. The drug is a generic version of Novartis’ Famvir.

Branded and generic versions of the drug had sales of $196 million in 2010, according to IMS Health.

April 18, 2011

The Food and Drug Administration has approved a topical treatment for skin conditions made by Israeli generic drug maker Taro Pharmaceutical Industries.

HAWTHORNE, N.Y. — The Food and Drug Administration has approved a topical treatment for skin conditions made by Israeli generic drug maker Taro Pharmaceutical Industries.

Taro announced Monday the approval of imiquimod cream in the 5% strength. The drug is used to treat actinic keratosis and external genital warts, and is a generic version of Graceway Pharmaceuticals’ Aldara.

Imiquimod cream has annual sales of around $340 million in the United States, according to Taro.

April 15, 2011

The Centers for Disease Control and Prevention is participating in a new docudrama that debuts on Animal Planet beginning Friday at 9 p.m., the agency announced earlier this week.

ATLANTA — The Centers for Disease Control and Prevention is participating in a new docudrama that debuts on Animal Planet beginning Friday at 9 p.m., the agency announced earlier this week.

Animal Planet has ordered six episodes of the new series “Killer Outbreaks.” Each episode features potentially deadly viruses and includes commentary from CDC experts and victims of the outbreaks. "Killer Outbreaks" began production in March 2010, and in total, producers interviewed 43 subject matter experts from across the agency.

April 12, 2011

Medication adherence among hepatitis C patients may improve when patients take antidepressants, according to a new analysis by pharmacy benefit manager Medco Health Solutions presented Monday at the International Conference on Viral Hepatitis.

BALTIMORE — Medication adherence among hepatitis C patients may improve when patients take antidepressants, according to a new analysis by pharmacy benefit manager Medco Health Solutions presented Monday at the International Conference on Viral Hepatitis.

April 8, 2011

Nine people died in Alabama last month after taking a compounded injectable supplement contaminated with bacteria, according to published reports.

NEW YORK — Nine people died in Alabama last month after taking a compounded injectable supplement contaminated with bacteria, according to published reports.

The New York Times reported that the patients died of infections with Serratia marcescens bacteria in hospitals after receiving the intravenously administered supplement total parenteral nutrition from the Birmingham, Ala.-based compounding pharmacy Meds IV Pharmacy.

April 7, 2011

U.S. marshals have seized more than $6 million in products distributed by Triad Group at the company’s facility in Hartland, Wis., the Food and Drug Administration reported Wednesday.

SILVER SPRING, Md. — U.S. marshals have seized more than $6 million in products distributed by Triad Group at the company’s facility in Hartland, Wis., the Food and Drug Administration reported Wednesday.

“We took this action to stop Triad from continuing to distribute products [that] may pose a risk to public health,” stated Dara Corrigan, FDA associate commissioner for regulatory affairs.

April 7, 2011

The National Advertising Division of the Council of Better Business Bureaus on Wednesday recommended that DSE Healthcare Solutions, which markets both Cystex urinary pain relief tablets and Cystex liquid cranberry complex with Proantinox, modify its advertising to better distinguish the two products.

NEW YORK — The National Advertising Division of the Council of Better Business Bureaus on Wednesday recommended that DSE Healthcare Solutions, which markets both Cystex urinary pain relief tablets and Cystex liquid cranberry complex with Proantinox, modify its advertising to better distinguish the two products.

April 5, 2011

The Food and Drug Administration has approved Boehringer Ingelheim Pharmaceuticals' single-pill antiretroviral for HIV-1 patients, BI said Tuesday.

RIDGEFIELD, Conn. — The Food and Drug Administration has approved Boehringer Ingelheim Pharmaceuticals' single-pill antiretroviral for HIV-1 patients, BI said Tuesday.

The FDA approved Viramune XR (nevirapine), a single-pill, once-daily, extended-release formulation of nevirapine for use in combination with other antiretroviral drugs.

March 29, 2011

A decision by the Food and Drug Administration to lower the age at which patients can receive a vaccine for shingles opens the door for pharmacists to administer it to more patients.

CAMP HILL, Pa. — A decision by the Food and Drug Administration to lower the age at which patients can receive a vaccine for shingles opens the door for pharmacists to administer it to more patients.

Rite Aid said Tuesday that pharmacists at more than 2,100 of its stores now could vaccinate patients ages 50 years and older with Merck’s Zostavax (zoster vaccine live) thanks to the FDA’s approval of the vaccination for patients in that age group. Previously, it was only approved for patients ages 60 years and older.

March 28, 2011

The Food and Drug Administration has approved a topical treatment for genital warts made by Graceway Pharmaceuticals, the drug maker said Monday.

BRISTOL, Tenn. — The Food and Drug Administration has approved a topical treatment for genital warts made by Graceway Pharmaceuticals, the drug maker said Monday.

The FDA approved Zyclara (imiquimod) cream in the 3.75% strength for patients ages 12 years and older. According to clinical trial data, the cream effectively cleared genital warts, and of patients who achieved complete clearance, only a small percentage had a recurrence 12 weeks after treatment.

March 25, 2011

The Food and Drug Administration has approved a vaccine for shingles in older patients.

SILVER SPRING, Md. — The Food and Drug Administration has approved a vaccine for shingles in older patients.

The agency said Thursday that it had approved Merck’s Zostavax (zoster vaccine live) vaccine in patients ages 50 to 59 years. The vaccine already is approved for those ages 60 years and older.

Shingles, caused by the varicella-zoster virus, the same virus that causes chickenpox, affects about 200,000 people in the United States ages 50 to 59 years each year.

March 24, 2011

The Food and Drug Administration has approved a generic treatment for shingles and genital herpes made by Actavis, the drug maker said Wednesday.

MORRISTOWN, N.J. — The Food and Drug Administration has approved a generic treatment for shingles and genital herpes made by Actavis, the drug maker said Wednesday.

The FDA approved Actavis’ valacyclovir hydrochloride tablets in the 500-mg and 1-g strengths.

The drug is a generic version of GlaxoSmithKline’s Valtrex. Branded and generic forms of the drug had sales of about $1.5 billion in 2010, according to IMS Health.

March 24, 2011

Sandoz has introduced an authorized generic version of a herpes treatment made by parent company Novartis, the company said Thursday.

PRINCETON — Sandoz has introduced an authorized generic version of a herpes treatment made by parent company Novartis, the company said Thursday.

Sandoz announced the launch of famciclovir tablets, an authorized generic of Famvir, used to treat genital herpes and cold sores in patients with healthy immune systems, and to treat shingles and herpes simplex infections of the skin and mucosa in patients with HIV.

Authorized generics are branded drugs sold under their generic chemical names at a reduced price, often through third-party companies.

March 22, 2011

A subsidiary of Watson Pharmaceuticals has launched a treatment for herpes infections, the company said Monday.

MORRISTOWN, N.J. — A subsidiary of Watson Pharmaceuticals has launched a treatment for herpes infections, the company said Monday.

Watson Labs launched famciclovir tablets in the 125-mg, 250-mg and 500-mg strengths. The drug is a generic version of Novartis’ Famvir and is used to treat cold sores and genital herpes in patients with and without HIV.

Famvir and generic versions had sales of about $197 million in 2010, according to IMS Health.

March 16, 2011

A new documentary film released by Institut Rosell-Lallemand discusses the discovery of beneficial bacteria and the role they play in our bodies, as well as the latest research on their potential to improve our lives.

MONTREAL — A new documentary film released by Institut Rosell-Lallemand discusses the discovery of beneficial bacteria and the role they play in our bodies, as well as the latest research on their potential to improve our lives.

“Microwarriors: The Power of Probiotics,” is available on DVD for an introductory price of $9.99. The film highlights probiotics and their contribution to overall health and well-being, the company said. The film was produced by Health Point Productions, a Los Angeles-based company.

March 14, 2011

GiantMicrobes has developed a new line of educational plush toys that are modeled after tiny organisms.

NEW YORK — GiantMicrobes has developed a new line of educational plush toys that are modeled after tiny organisms.

New to the lineup are toys that resemble magnified microbes of hay fever, a tick and a brain cell.

Original-sized GiantMicrobes (5-in. to 7-in. sizes) retail for $8.95, while GiantMicrobes petri dishes (three mini-microbes packaged in a dish) retail for $12.95, and Gigantics (15-in. to 20-in. sizes) retail for $29.95. The brain cell plush toy is available as a key chain, GiantMicrobes said, and retails for $5.95.